High Court Won't Hear Respiratory Treatment Patent Suit
The U.S. Supreme Court on Monday declined to take up Mallinckrodt's appeal of a split Federal Circuit decision that a treatment method that calls for withholding the respiratory drug Inomax from...To view the full article, register now.
Already a subscriber? Click here to view full article